13 May 2021

Patenting Psychoactives—The Psilocybin Patent Race

More and more medical uses of psychoactives are coming forward creating somewhat of a gold rush for psilocybin patents.  As plants that are medicines can’t be patented, it is synthesised molecules and method of delivery patents which are highly sought after.  Join us as we discuss:

  1. Why is there currently a boom in psychedelic patents?
  2. What should and shouldn’t be protected as IP?
  3. What lessons can be learned from the cannabis patent market?
  4. Why are companies leaning towards filing for provisional patents over formal applications in this field?

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk